ICU Medical Inc
ICUINasdaqCIK 883984HealthcareFiscal year ends Dec 31
Reports and events: 278 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0616:34 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000883984-26-000041 |
| 2026-08-0616:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-26-000040 |
| 2026-05-1812:35 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000883984-26-000031 |
| 2026-05-0716:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000883984-26-000029 |
| 2026-05-0716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-26-000028 |
| 2026-04-0216:07 ET | DEF 14A | Proxy statementPeriod 2026-05-13 | 0000883984-26-000019 |
| 2026-02-2016:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000883984-26-000010 |
| 2026-02-1916:40 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000883984-26-000008 |
| 2026-02-1916:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-26-000007 |
| 2025-11-0616:39 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000883984-25-000035 |
| 2025-11-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-25-000034 |
| 2025-08-0716:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000883984-25-000030 |
| 2025-08-0716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-25-000029 |
| 2025-05-1414:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000883984-25-000018 |
| 2025-05-0817:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000883984-25-000016 |
| 2025-05-0816:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-25-000014 |
| 2025-04-0313:19 ET | DEF 14A | Proxy statementPeriod 2025-04-03 | 0000883984-25-000010 |
| 2025-02-2717:24 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000883984-25-000007 |
| 2025-02-2716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-25-000006 |
| 2024-11-1217:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000883984-24-000042 |
| 2024-11-1216:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-24-000040 |
| 2024-10-0216:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000883984-24-000032 |
| 2024-08-0717:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000883984-24-000030 |
| 2024-08-0716:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-24-000028 |
| 2024-07-1807:06 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-033442 |
| 2024-05-1614:55 ET | 8-K | 5.07 Shareholder vote results | 0000883984-24-000018 |
| 2024-05-0716:29 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000883984-24-000016 |
| 2024-05-0716:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-24-000014 |
| 2024-04-0210:46 ET | DEF 14A | Proxy statementPeriod 2024-05-15 | 0000883984-24-000010 |
| 2024-03-0116:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-019011 |
| 2024-02-2908:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000883984-24-000007 |
| 2024-02-2717:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000883984-24-000005 |
| 2024-02-2716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-24-000004 |
| 2023-11-0616:57 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000883984-23-000038 |
| 2023-11-0616:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-23-000037 |
| 2023-11-0316:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000883984-23-000034 |
| 2023-08-0717:22 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000883984-23-000030 |
| 2023-08-0716:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-23-000029 |
| 2023-05-2216:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000883984-23-000024 |
| 2023-05-0917:34 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000883984-23-000022 |
| 2023-05-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-23-000020 |
| 2023-04-0416:26 ET | DEF 14A | Proxy statement | 0000883984-23-000015 |
| 2023-02-2717:31 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000883984-23-000009 |
| 2023-02-2716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-23-000007 |
| 2023-01-0316:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000883984-23-000003 |
| 2022-11-0717:27 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000883984-22-000047 |
| 2022-11-0716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-22-000044 |
| 2022-08-0919:34 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000883984-22-000041 |
| 2022-08-0816:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000883984-22-000039 |
| 2022-05-1810:21 ET | 8-K | 5.07 Shareholder vote results | 0000883984-22-000032 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.